Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$272M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$198M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$190M |
| 4 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$178M |
| 5 |
Public Storage
PSA
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$703M |
| 2 |
Microsoft
MSFT
|
+$383M |
| 3 |
KSU
Kansas City Southern
KSU
|
+$278M |
| 4 |
iShares MSCI India ETF
INDA
|
+$265M |
| 5 |
Meta Platforms (Facebook)
META
|
+$166M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.64% |
| 2 | Healthcare | 12.43% |
| 3 | Financials | 11.77% |
| 4 | Consumer Discretionary | 11.33% |
| 5 | Communication Services | 8.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYRS
3301
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $1.71M | ﹤0.01% |
52,488
+20
| +0% | +$810 |
|
3302
Fortress Biotech
FBIO
$99M
| $1.71M | ﹤0.01% |
45,552
+964
| +2% | +$43K |
|
|
MRUS
3303
DELISTED
Merus
MRUS
| $1.7M | ﹤0.01% |
53,549
+7,955
| +17% | +$225K |
|
|
SPYM
3304
State Street SPDR Portfolio S&P 500 ETF
SPYM
$170B
| $1.7M | ﹤0.01% |
30,494
-275
| -0.9% | -$14.8K |
|
|
HGEN
3305
DELISTED
HUMANIGEN, INC.
HGEN
| $1.7M | ﹤0.01% |
457,593
+19,677
| +4% | +$115K |
|
3306
Roivant Sciences
ROIV
$26.2B
| $1.7M | ﹤0.01% |
+168,344
| New | +$1.4M |
|
3307
Establishment Labs
ESTA
$2.25B
| $1.69M | ﹤0.01% |
25,077
-435
| -2% | -$30.4K |
|
|
ATHX
3308
DELISTED
Athersys, Inc. Common Stock
ATHX
| $1.69M | ﹤0.01% |
74,853
-7,289
| -9% | -$209K |
|
|
ESPR
3309
DELISTED
Esperion Therapeutics
ESPR
| $1.69M | ﹤0.01% |
337,157
+42,315
| +14% | +$339K |
|
3310
Schwab US Large-Cap Growth ETF
SCHG
$63.2B
| $1.69M | ﹤0.01% |
82,368
+10,912
| +15% | +$218K |
|
|
NAGE
3311
Niagen Bioscience
NAGE
$241M
| $1.68M | ﹤0.01% |
449,462
+3,033
| +0.7% | +$16.4K |
|
3312
Atossa Therapeutics
ATOS
$25.5M
| $1.68M | ﹤0.01% |
69,966
-2,202
| -3% | -$80.6K |
|
3313
Viper Energy
VNOM
$14.8B
| $1.68M | ﹤0.01% |
78,821
+26,339
| +50% | +$590K |
|
|
AKYA
3314
DELISTED
Akoya BioSciences
AKYA
| $1.67M | ﹤0.01% |
108,939
+38,186
| +54% | +$500K |
|
3315
Definitive Healthcare
DH
$68.4M
| $1.66M | ﹤0.01% |
+60,825
| New | +$2.13M |
|
3316
Spyre Therapeutics
SYRE
$8.98B
| $1.66M | ﹤0.01% |
13,988
-640
| -4% | -$101K |
|
3317
Grupo Aeroportuario del Sureste
ASR
$8.01B
| $1.65M | ﹤0.01% |
8,026
-606
| -7% | -$120K |
|
3318
Procept Biorobotics
PRCT
$1.26B
| $1.65M | ﹤0.01% |
+66,061
| New | +$2.44M |
|
3319
PAVmed
PAVM
$33.9M
| $1.65M | ﹤0.01% |
1,487
-9
| -0.6% | -$19.6K |
|
3320
Hims & Hers Health
HIMS
$6.71B
| $1.64M | ﹤0.01% |
250,081
+38
| +0% | +$275 |
|
3321
Lyell Immunopharma
LYEL
$337M
| $1.64M | ﹤0.01% |
10,579
-113
| -1% | -$25.2K |
|
3322
Century Therapeutics
IPSC
$349M
| $1.64M | ﹤0.01% |
103,167
-621
| -0.6% | -$11.7K |
|
3323
Safe Bulkers
SB
$781M
| $1.64M | ﹤0.01% |
434,096
-3,589
| -0.8% | -$14.6K |
|
3324
HBT Financial
HBT
$1.35B
| $1.63M | ﹤0.01% |
86,792
+647
| +0.8% | +$11.7K |
|
|
CSLT
3325
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $1.62M | ﹤0.01% |
1,054,665
+9,319
| +0.9% | +$15.4K |
|
Similar funds
Northern Trust's Q4 2021 Portfolio in Review
As of Q4 2021, Northern Trust held 4,871 positions worth $610B, up 8% from $565B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Northern Trust's Q4 2021 filing shows 218 new, 1,492 increased, 2,680 reduced and 100 closed positions. Its largest new stake was Rivian: 874,044 shares worth $90.6M. The largest sale was Apple, an estimated $703M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Northern Trust's largest Q4 2021 buy was Rivian: 874,044 shares worth $90.6M.
- Northern Trust added most to iShares Russell 1000 ETF in Q4 2021, an estimated $272M increase.
- Northern Trust's biggest Q4 2021 reduction was Apple, cutting an estimated $703M.
- Northern Trust fully exited Kansas City Southern in Q4 2021, selling an estimated $278M.
- Northern Trust's ten largest holdings make up 23% of its $610B portfolio in Q4 2021.
- Northern Trust opened 218 new positions and closed 100 in Q4 2021.
- Northern Trust's portfolio value rose 8% quarter-over-quarter to $610B.
Based on Northern Trust's 13F filing for Q4 2021, filed 8 Feb 2022.